Abrilumab ( DrugBank: Abrilumab )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1
97	潰瘍性大腸炎	1

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01696396 (ClinicalTrials.gov)	December 4, 2012	27/9/2012	Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease	A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Effic ...	Crohn's Disease	Drug: Abrilumab;Drug: Placebo	Amgen	NULL	Completed	18 Years	65 Years	All	254	Phase 2	United States;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Netherlands;Switzerland; ...

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01694485 (ClinicalTrials.gov)	November 16, 2012	24/9/2012	Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis	A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerabil ...	Ulcerative Colitis	Biological: Abrilumab;Drug: Placebo	Amgen	NULL	Completed	18 Years	65 Years	All	359	Phase 2	United States;Australia;Austria;Belgium;Canada;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary ...